Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center are the first in the region to have joined a nationwide clinical trial to evaluate the effectiveness of a gene therapy in patients with advanced melanoma which is aimed to help a patient’s own immune system fight their cancer. The gene therapy is termed Allovectin-7®, and is injected directly into the cancer while it is still in the body in order to make it appear foreign to the immune system. [click link for full article]